APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $13.1M invested in Aptevo Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$665K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$560K
2
+$365K

Top Sellers

1
-$703K
2
-$518K
3
-$497K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$414K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$207K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$22K
27
$19K
28
$13K
29
$13K
30
$12K
31
$11K
32
$11K
33
$10K
34
$10K
35
$7K
36
$5K
37
$2K
38
$1K
39
$1K
40
$88
41
$6
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3